tiprankstipranks
Agilent (DE:AG8)
FRANKFURT:AG8

Agilent (AG8) Stock Price & Analysis

2 Followers

AG8 Stock Chart & Stats

Day’s Range€0 - €0
52-Week Range€94.80 - €136.65
Previous Close€124.4
Volume0.00
Average Volume (3M)150.00
Market Cap
€36.83B
Enterprise Value€37.66B
Total Cash (Recent Filing)$1.75B
Total Debt (Recent Filing)$2.56B
Price to Earnings (P/E)N/A
Beta0.67
May 21, 2024
Dividend Yield0.69%
Share Statistics
EPS (TTM)N/A
Shares Outstanding293,055,284
10 Day Avg. Volume84
30 Day Avg. Volume150
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)21.88
Price to Sales (P/S)20.58
Price to Cash Flow (P/CF)20.10
P/FCF Ratio23.50
Enterprise Value/Market CapN/A
Enterprise Value/Revenue5.54
Enterprise Value/Gross Profit10.12
Enterprise Value/Ebitda22.43
Forecast
Price Target Upside13.84% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13

Bulls Say, Bears Say

Bulls Say
Company OutlookAnalyst upgrades Agilent to 'Buy' based on the strong second half acceleration in instrument demand, signaling increased attractiveness of the company in the market.
Financial PerformanceAgilent's first quarter results exceeded expectations with a book-to-bill ratio above one, reflecting a healthy order volume and potential for sustained growth.
Leadership And StrategyAgilent's leadership, under CEO McMullen, has demonstrated a track record of driving significant sales and margin expansion, positioning the company for continued success.
Bears Say
Industry OutlookA more cautious outlook cannot be positive for the international oilfield services industry.
Leadership ChangesThe timing of CEO McMullen's retirement announcement may have come as a surprise to investors.
Market ConditionsThe market backdrop continues to remain challenged, suggesting potential headwinds for the company.
---

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

0.00%0.00%1.07%98.93%
1.07% Other Institutional Investors
98.93% Public Companies and
Individual Investors

AG8 FAQ

What was Agilent’s price range in the past 12 months?
Agilent lowest stock price was €94.80 and its highest was €136.65 in the past 12 months.
    What is Agilent’s market cap?
    Currently, no data Available
    When is Agilent’s upcoming earnings report date?
    Agilent’s upcoming earnings report date is May 21, 2024 which is in 28 days.
      How were Agilent’s earnings last quarter?
      Agilent released its earnings results on Feb 27, 2024. The company reported €1.209 earnings per share for the quarter, beating the consensus estimate of €1.148 by €0.061.
        Is Agilent overvalued?
        According to Wall Street analysts Agilent’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Agilent pay dividends?
          Agilent pays a Quarterly dividend of €0.22 which represents an annual dividend yield of 0.69%. See more information on Agilent dividends here
            What is Agilent’s EPS estimate?
            Agilent’s EPS estimate is €1.12.
              How many shares outstanding does Agilent have?
              Currently, no data Available
              What happened to Agilent’s price movement after its last earnings report?
              Agilent reported an EPS of €1.209 in its last earnings report, beating expectations of €1.148. Following the earnings report the stock price went up 5.62%.
                Which hedge fund is a major shareholder of Agilent?
                Among the largest hedge funds holding Agilent’s share is PRIMECAP Management Co. It holds Agilent’s shares valued at 282M.
                  ---

                  Company Description

                  Agilent

                  Agilent Technologies, Inc. is an analytical instrumentation development and manufacturing company. The company provides instruments, software, services, consumables, and expertise to address the full range of scientific and laboratory management needs.
                  ---

                  AG8 Company Deck

                  ---

                  AG8 Earnings Call

                  Q1 2024
                  0:00 / 0:00
                  ---

                  AG8 Revenue Breakdown

                  56.43%56.43%22.95%20.62%
                  56.43% Life Sciences and Applied Markets
                  22.95% Agilent CrossLab
                  20.62% Diagnostics and genomics
                  tipranks
                  ---

                  AG8 Stock 12 Months Forecast

                  Average Price Target

                  €141.62
                  ▲(13.84% Upside)
                  {"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"plus_tr_sans","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"100":"€100","155":"€155","113.75":"€113.8","127.5":"€127.5","141.25":"€141.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":154.6578,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n  <span style=\"color:#199ca5\">€154.66</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":141.6196788,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n  <span style=\"color:#828080\">€141.62</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":123.72624,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n  <span style=\"color:#912767\">€123.73</span>\n  </div></div>","useHTML":true}}],"tickPositions":[100,113.75,127.5,141.25,155],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2023","6":"Oct<br/>2023","9":"Jan<br/>2024","12":"Apr<br/>2024","25":"Apr<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,131.36,133.15213846153847,134.94427692307693,136.73641538461538,138.52855384615387,140.32069230769233,142.11283076923078,143.90496923076924,145.6971076923077,147.48924615384615,149.28138461538464,151.0735230769231,152.86566153846155,{"y":154.6578,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,131.36,132.14920606153848,132.93841212307694,133.7276181846154,134.51682424615385,135.3060303076923,136.09523636923078,136.88444243076924,137.6736484923077,138.46285455384617,139.2520606153846,140.04126667692307,140.83047273846154,{"y":141.6196788,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,131.36,130.7727876923077,130.1855753846154,129.59836307692308,129.01115076923077,128.42393846153848,127.83672615384616,127.24951384615386,126.66230153846155,126.07508923076924,125.48787692307693,124.90066461538463,124.31345230769232,{"y":123.72624,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":122.358,"date":1682035200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":120.917,"date":1683244800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":107.045,"date":1685664000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":107.801,"date":1688688000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":112.832,"date":1691107200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":110.939,"date":1693526400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":103.924,"date":1696550400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":101.328,"date":1698969600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":116.603,"date":1701388800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":118.35,"date":1704412800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":121.85,"date":1706832000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":126.8,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":131.36,"date":1712275200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Agilent
                  Abbott Labs
                  Amgen
                  Bio-Rad Laboratories
                  Danaher

                  Best Analysts Covering AG8

                  1 Year
                  1 Year Success Rate
                  26/32 ratings generated profit
                  81%
                  1 Year Average Return
                  +20.31%
                  reiterated a buy rating 2 months ago
                  Copying Brandon Couillard's trades and holding each position for 1 Year would result in 81.25% of your transactions generating a profit, with an average return of +20.31% per trade.
                  Popular Stocks
                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis